259 related articles for article (PubMed ID: 27924722)
1. Distinct Biomarkers for Early Diagnosis of Diabetic Nephropathy.
Kishore L; Kaur N; Singh R
Curr Diabetes Rev; 2017; 13(6):598-605. PubMed ID: 27924722
[TBL] [Abstract][Full Text] [Related]
2. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
[TBL] [Abstract][Full Text] [Related]
3. Diabetic nephropathy: traditional to proteomic markers.
Moresco RN; Sangoi MB; De Carvalho JA; Tatsch E; Bochi GV
Clin Chim Acta; 2013 Jun; 421():17-30. PubMed ID: 23485645
[TBL] [Abstract][Full Text] [Related]
4. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
5. [Early detection of diabetic nephropathy].
Murussi M; Murussi N; Campagnolo N; Silveiro SP
Arq Bras Endocrinol Metabol; 2008 Apr; 52(3):442-51. PubMed ID: 18506269
[TBL] [Abstract][Full Text] [Related]
6. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
Shoukry A; Bdeer Sel-A; El-Sokkary RH
Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
[TBL] [Abstract][Full Text] [Related]
7. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
Bessa SS; Hussein TA; Morad MA; Amer AM
Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
[TBL] [Abstract][Full Text] [Related]
8. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
[TBL] [Abstract][Full Text] [Related]
9. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
10. Urinary heme oxygenase-1 as a potential biomarker for early diabetic nephropathy.
Li Z; Xu Y; Liu X; Nie Y; Zhao Z
Nephrology (Carlton); 2017 Jan; 22(1):58-64. PubMed ID: 26733347
[TBL] [Abstract][Full Text] [Related]
11. Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy.
Ye H; Bai X; Gao H; Li L; Wu C; Sun X; Zhang C; Shen Y; Zhang J; Lu Z
J Diabetes Complications; 2014; 28(1):96-100. PubMed ID: 24075693
[TBL] [Abstract][Full Text] [Related]
12. Urinary copper excretion in type 2 diabetic patients with nephropathy.
Ito S; Fujita H; Narita T; Yaginuma T; Kawarada Y; Kawagoe M; Sugiyama T
Nephron; 2001 Aug; 88(4):307-12. PubMed ID: 11474224
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking and increased urine albumin excretion are interrelated predictors of nephropathy progression in type 2 diabetes.
Chuahirun T; Khanna A; Kimball K; Wesson DE
Am J Kidney Dis; 2003 Jan; 41(1):13-21. PubMed ID: 12500217
[TBL] [Abstract][Full Text] [Related]
14. Adipokine zinc-alpha-2-glycoprotein as a novel urinary biomarker presents earlier than microalbuminuria in diabetic nephropathy.
Wang Y; Li YM; Zhang S; Zhao JY; Liu CY
J Int Med Res; 2016 Apr; 44(2):278-86. PubMed ID: 26857862
[TBL] [Abstract][Full Text] [Related]
15. The association between methylation levels of targeted genes and albuminuria in patients with early diabetic kidney disease.
Aldemir O; Turgut F; Gokce C
Ren Fail; 2017 Nov; 39(1):597-601. PubMed ID: 28805547
[TBL] [Abstract][Full Text] [Related]
16. Urinary Smad1 is a new biomarker for diagnosis and evaluating the severity of diabetic nephropathy.
Li Q; Feng L; Li J; Chen Q
Endocrine; 2014 May; 46(1):83-9. PubMed ID: 23943254
[TBL] [Abstract][Full Text] [Related]
17. Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes.
Viana LV; Gross JL; Camargo JL; Zelmanovitz T; da Costa Rocha EP; Azevedo MJ
J Diabetes Complications; 2012; 26(5):407-12. PubMed ID: 22677793
[TBL] [Abstract][Full Text] [Related]
18. Urinary mRNA markers of epithelial-mesenchymal transition correlate with progression of diabetic nephropathy.
Zheng M; Lv LL; Cao YH; Zhang JD; Wu M; Ma KL; Phillips AO; Liu BC
Clin Endocrinol (Oxf); 2012 May; 76(5):657-64. PubMed ID: 21824169
[TBL] [Abstract][Full Text] [Related]
19. Changes in urine proteome accompanying diabetic nephropathy progression.
Lewandowicz A; Bakun M; Kohutnicki R; Fabijańska A; Kistowski M; Imiela J; Dadlez M
Pol Arch Med Wewn; 2015; 125(1-2):27-38. PubMed ID: 25578432
[TBL] [Abstract][Full Text] [Related]
20. Urine synaptopodin excretion is an important marker of glomerular disease progression.
Kwon SK; Kim SJ; Kim HY
Korean J Intern Med; 2016 Sep; 31(5):938-43. PubMed ID: 27604800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]